Nicotine reduces antisaccade errors in task impaired schizophrenic subjects

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 28, Issue 3, 2004, Pages 505-516

  Larrison Faucher, Abigail L ^a   Matorin, Anu A ^b   Sereno, Anne B ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b University of Texas Mental Sciences Institute   (United States)

Author keywords

ANAM; Antisaccade; AS; Attention; Automated Neuropsychological Assessment Metrics; Carbon monoxide; CO; CONT; Continuous performance test; Control group; CPT; EP; Evoked potentials; Identical pairs; IP; ISI; Nicotine; Saccade; Schizophrenia

Indexed keywords

NICOTINE GUM; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EYE MOVEMENT; FEMALE; FOLLOW UP; FUNCTION TEST; HUMAN; MALE; MENTAL PATIENT; REACTION TIME; SACCADIC EYE MOVEMENT; SCHIZOPHRENIA; TASK PERFORMANCE;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NICOTINE; NICOTINIC AGONISTS; PRACTICE (PSYCHOLOGY); PSYCHOMOTOR PERFORMANCE; PURSUIT, SMOOTH; REACTION TIME; SACCADES; SCHIZOPHRENIC PSYCHOLOGY;

EID: 1842839795     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2004.01.002     Document Type: Article

References (75)

1. Adler L.E., Pachtman E., Franks R., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol. Psychiatry. 17:1982;639-654.
2. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry. 150(12):1993;1856-1861.
3. Andresen B., Lammers C.H., Thom E., Sternkopf G. SPEM disturbances, schizophrenia and smoking. J. Psychophysiol. 3:1989;311.
4. Benowitz N.L., Porchet H., Sheiner L., Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin. Pharmacol. Ther. 44(1):1988;23-28.
5. Beratis S., Katrivanou A., Gourzis P. Factors affecting smoking in schizophrenia. Compr. Psychiatry. 42(5):2001;393-402.
6. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: human and animal model studies. Arch. Gen. Psychiatry. 47:1990;171-197.
7. Burke J.G., Reveley M.A. Improved antisaccade performance with risperidone in schizophrenia. J. Neurol. Neurosurg. Psychiatry. 72:2002;449-454.
8. Cleghorn J.M., Kaplan R.D., Szechtman B., Szechtman H., Brown G.M. Neuroleptic drug effects on cognitive function in schizophrenia. Schizophr. Res. 3:1990;211-219.
9. Combs D.R., Advokat A. Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia. Schizophr. Res. 46:2000;129-137.
10. Conners, C.K., 1995. The continuous performance test. Computer Program, Toronto, Multi-Health Systems.
11. Cornblatt B.A., Risch N.J., Faris G., Friedman D., Erlenmeyet-Kimling L. The Continuous Performance Task, Identical Pair Version (CPT-IP): new findings about sustained attention in normal families. Psychiatry Res. 26:1988;223-238.
12. Crawford T.J., Haeger B., Kennard C., Revely M.A., Henderson L. Saccadic abnormalities in psychotic patients: I. Neuroleptic-free psychotic patients. Psychol. Med. 25:1995;461-471.
13. Dalack G.W., Meador-Woodruff J.H. Smoking, smoking withdrawal and schizophrenia: case reports and a review of the literature. Schizophr. Res. 22(2):1996;133-141.
14. deLeon J. Smoking and vulnerability for schizophrenia. Schizophr. Bull. 22(3):1996;405-409.
15. deLeon J., Dadvand M., Canuso C., White A.O., Stanilla J.K., Simpson G.M. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry. 152(3):1995;453-455.
16. Dépatie L., O'Driscoll G.A., Holahan A.V., Atkinson V., Thavundayil J.X., Kin N.N., Lal S. Nicotine and behavioral markers of risk for schizophrenia: a double-blind placebo-controlled, cross-over study. Neuro-psychopharmacology. 27(6):2002;1056-1070.
17. Fischer B., Ramsperger E. Human express-saccades: extremely short reaction times of goal directed eye movements. Exp. Brain Res. 57:1984;191-195.
18. Fischer B., Weber H. Characteristics of "anti" saccades in man. Exp. Brain Res. 89:1992;415-424.
19. Franks R.D., Adler L.E., Waldo M.C., Alpert J., Freedman R. Neurophysiological studies of sensory gating in mania: comparison with schizophrenia. Biol. Psychiatry. 18:1983;989-1005.
20. Freedman R., Adler L.E., Waldo M.C., Pachtman E., Franks R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophreina: comparison of medicated and drug-free patients. Biol. Psychiatry. 18:1983;537-551.
21. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry. 38:1995;22-33.
22. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymoropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to chromosome 15 locus. PNAS. 94:1997;587-592.
23. Fukushima J., Fukushima K., Tatsuo C., Tanaka S. Disturbances of voluntary control of saccadic eye movements in schizophrenic patients. Biol. Psychiatry. 23(7):1988;670-677.
24. Fukushima J., Kikuro F., Nobuyuki M., Yamashita I. Further analysis of the control of voluntary saccadic eye movements in schizophrenic patients. Biol. Psychiatry. 28(11):1990;943-958.
25. Fukushima J., Nobuyuki M., Fukushima K., Tatsuo C. Voluntary control of saccadic eye movements in patients with schizophrenic and affective disorders. J. Psychiatr. Res. 24(1):1990;9-24.
26. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., Kosten T.R., Wexler B.E. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuro-psychopharmacology. 26(1):2002;75-85.
27. Hallett P.E. Primary and secondary saccades to goals defined by instructions. Vis. Res. 18:1978;1279-1296.
28. Holzman P.S., Proctor L.R., Hughes D.W. Eye-tracking patterns in schizophrenia. Science. 181:1973;179-181.
29. Holzman P.S., Levy D.L., Proctro L.R. Smooth pursuit eye movements, attention, and schizophrenia. Arch. Gen. Psychiatry. 33:1976;1415-1420.
30. Hughes J.R., Hatsukami D.K., Mitchell J.E., Dahlgren L.A. Prevalence of smoking among psychiatric outpatients. Am. J. Psychiatry. 143:1986;993-997.
31. Karoumi B., Ventre-Dominey J., Vighetto A., Salery J., d'Amato T. Saccadic eye movements in schizophrenic patients. Psychiatry Res. 77(1):1998;9-19.
32. Klein C., Andresen B. On the influence of smoking upon smooth pursuit eye movements of schizophrenics and normal controls. J. Psychophysiol. 5:1991;361-369.
33. Larrison-Faucher A.L., Briand K.A., Sereno A.B. Delayed onset of inhibition of return in schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26:2002;505-512.
34. Larrison-Faucher A.L., Briand K.A., Sereno A.B. Nicotine enhances antisaccade task performance without affecting prosaccades. 33rd Annual Meeting Society for Neuroscience Abstracts. 2003;515.27.
35. Lawrie S.M., Hutchison J.K., Sweeney S.R., Fernando M.R., McAdam C.A., Monsour M.R., Campbell T.J., MacLeod C.M. Psychosis and substance abuse: cause, effect or coincidence? Scott. Med. J. 40(6):1995;174-176.
36. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22(3):1996;431-445.
37. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
38. Levin E.D., Wilson W., Rose J.E., McEnvoy J. Nicotine Haloperidol interactions and cognitive performance in schizophrenics. Neuro- psychopharmacology. 15(5):1996;429-436.
39. Levy D.L., Holzman P.S., Mathysse S., Mendell N.R. Eye tracking dysfunction and schizophrenia: a critical perspective. Schizophr. Bull. 19(3):1993;461-506.
40. Levy D.L., Holzman P.S., Matthysse S., Mendell N.R. Eye tracking and schizophrenia: a selective review. Schizophr. Bull. 20(1):1994;47-62.
41. Levy D.L., Mendell N.R., LaVancher C.A., Brownstein J., Krastoshevsky O., Terapulsky L., McManus K.S., Lo Y., Bloom R., Matthysse S., Holzman P.S. Disinhibition in antisaccade performance in schizophrenia. Lenzenweger M.F., Dworkin R.H. Origins and Development of Schizophrenia: Advances in Experimental Psychopathology. 1998;185-210 American Psychological Association, Washington, DC.
42. Light G.A., Geyer M.A., Clementz B.A., Cadenhead K.S., Braff D.L. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am. J. Psychiatry. 157:2000;767-771.
43. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophr. Res. 8(2):1992;93-102.
44. Long G.M., Franklin M.E. The effects of smoking (nicotine nystagmus) on dynamic visual acuity. Bull. Psychon. Soc. 27(2):1989;163-166.
45. McEvoy J., Freudenreich O., Levin E., Rose J. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology. 119(1):1995;124-126.
46. McEvoy J., Freudenreich O., McGee M., VanderZwaag C., Levin E., Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol. Psychiatry. 37(8):1995;550-552.
47. Miller R.R. Effects of smoking on drug action. Pharmacol. Ther. 2:1977;749-756.
48. Norman T.R., Chamberlain K.G., French M.A., Burrows G.D. Platelet monoamine oxidase activity and cigarette smoking. J. Affect. Disord. 4:1982;73-77.
49. Nuechterlein K.H. Vigilance in schizophrenia and related disorders. Steinhauer S.R., Gruzelier J.H., Zubin J. Handbook of Schizophrenia: Neuropsychology, Psychophysiology and Information Process. vol. 5:1991;397-433 Elsevier, Amsterdam.
50. O'Farrell T.J., Connors G.J., Upper D. Addictive behaviors among hospitalized schizophrenic patients. Addict. Behav. 8:1983;329-333.
51. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuro-psychopharmacology. 18(3):1998;175-185.
52. Olincy A., Johnson L.L., Ross R.G. Differential effects of cigarette smoking on performance of a smooth pursuit and a saccadic eye movement task in schizophrenia. Psychiatry Res. 117(3):2003;223-236.
53. Orzack M., Kornetsky C. Attention dysfunction in chronic schizophrenia. Arch. Gen. Psychiatry. 14:1966;323-326.
54. Poirier M.F., Canceil O., Bayle F., Millet B., Bourdel M.C., Moatti C., Olie J.P., Attar-Levy D. Prevalence of smoking in psychiatric patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26(3):2002;529-537.
55. Pritchard W. The link between smoking and P: a serotonergic hypothesis. Pers. Individ. Differ. 12(11):1991;1187-1204.
56. Pritchard W.S., Robinson J.H. Effects of nicotine on human performance. Snel J., Lorist M.M. Nicotine, Caffeine and Social Drinking: Behaviour and Brain Function. 1998;21-81 Harwood Academic, Amsterdam.
57. Reeves D., Kane R., Winter K., Raynsford K., Pancella T. Automated Neuropsychological Assessment Metrics (ANAM): Test Administrator's Guide Version 1.0. 1993;Inst. Mental Health, St. Louis, MO.
58. Reuter-Lorenz P.A., Hughes H.C., Fendrich R. The reduction of saccadic latency by prior offset of the fixation point: an analysis of the gap effect. Percept. Psychophys. 49(2):1991;167-175.
59. Reveley M.A., Burke J.G., Dursun S.M., Andrews H., Patel J.K.M., Simms M. Saccadic eye movement abnormalities in schizophrenic patients treated with clozapine, risperidone or sulperide. Schizophr. Res. 18(2):1996;222.
60. Rosvold H.E., Mirsky A.F., Sarason I., Bransome E.D., Beck L.H. A continuous performance test of brain damage. J. Consult. Psychol. 20:1956;343-350.
61. Sandyk R. Cigarette smoking: effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia. Int. J. Neurosci. 70:1993;193-197.
62. Schacter S. Pharmacological and psychological determinants of smoking. Thornton R.E. Smoking Behaviour: Physiological and Psychological Influences. 1978;Churchill Livingstone, London.
63. Sereno A.B., Holzman P.S. Express saccades and smooth pursuit eye movement function in schizophrenic, affective disorder, and normal subjects. J. Cogn. Neurosci. 5:1993;303-316.
64. Sereno A.B., Holzman P.S. Antisaccades and smooth pursuit eye movements in schizophrenic, affective disorder, and normal subjects. Biol. Psychiatry. 37:1995;394-401.
65. Sherr J.D., Myers C., Avila M.T., Elliott A., Blaxton T.A., Thaker G.K. The effects of nicotine on specific eye tracking measures in schizophrenia. Biol. Psychiatry. 52:2002;721-728.
66. Sibony P.A., Evinger C., Manning K.A. Tobacco-induced primary-position upbeat nystagmus. Ann. Neurol. 21(1):1987;53-58.
67. Sibony P.A., Evinger C., Manning K.A. The effects of tobacco smoking on smooth pursuit eye movements. Ann. Neurol. 23(3):1988;238-241.
68. Smith R.C., Singh A., Infante M., Khandat A., Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuro-psychopharmacology. 27(3):2002;479-497.
69. Thaker G.K., Ellsberry M.M., Lahti A., Tamminga C. Tobacco smoking increases square-wave jerks during pursuit eye movements. Biol. Psychiatry. 29:1991;82-88.
70. van den Bosch R.J., Rombouts R.P., van Asma M.J. What determines continuous performance task performance. Schizophr. Bull. 22(4):1996;643-651.
71. Warburton D.M. Caffeine, nicotine and attentional performance. Snel J., Lorist M.M. Nicotine, Caffeine and Social Drinking: Behaviour and Brain Function. 1998;245-256 Harwood Academic, Amsterdam.
72. Waters A.J., Sutton S.R. Direct and indirect effects of nicotine/smoking on cognition in humans. Addict. Behav. 25(1):2000;29-43.
73. Wesnes K., Warburton D.M. The effects of cigarette smoking and nicotine tablets upon human attention. Thornton R.E. Smoking Behaviour: Physiological and Psychological Influences. 1978;131-147 Churchill Livingstone, London.
74. Wesnes K., Warburton D.M. Smoking, nicotine and human performance. Pharmacol. Ther. 21:1983;189-208.
75. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hosp. Comm. Psychiatry. 45(3):1994;204-206.